54
edits
Changes
PHAC Conflict of Interest Toolkit for Guideline Development (view source)
Revision as of 14:22, 31 March 2020
, 14:22, 31 March 2020→PHAC COI assessment tool for guideline development: - adding text
== PHAC COI assessment tool for guideline development ==
== PHAC COI assessment tool for guideline development ==
There is an important distinction to make between disclosed interests, and the presence of COI. Expert advisory panelists providing advice to PHAC or otherwise developing guidance (e.g., clinical practice guidelines) may have a wide variety of affiliations and interests. As noted by the World Health Organization, "''The declaration of one or more secondary interests (declaration of interests) does not automatically mean that a conflict of interest is present: there is a distinction between the two. A transparent and objective process for assessing a declaration of interests is required to determine if a conflict exists and what its effects might be, and to manage any significant conflict of interest."''<ref>World Health Organization. WHO handbook for guideline development (2nd Edition); Chapter 6 Declaration and management of interest. WHO 2014. Available from: <nowiki>https://apps.who.int/medicinedocs/en/m/abstract/Js22083en/</nowiki></ref> Figure 1 provides an overview of the link between disclosures of interests, and the identification and management of COI.
There is an important distinction to make between disclosed interests, and the presence of COI. Expert advisory panelists providing advice to PHAC or otherwise developing guidance (e.g., clinical practice guidelines) may have a wide variety of affiliations and interests. As noted by the World Health Organization, "''The declaration of one or more secondary interests (declaration of interests) does not automatically mean that a conflict of interest is present: there is a distinction between the two. A transparent and objective process for assessing a declaration of interests is required to determine if a conflict exists and what its effects might be, and to manage any significant conflict of interest."''<ref>World Health Organization. WHO handbook for guideline development (2nd Edition); Chapter 6 Declaration and management of interest. WHO 2014. Available from: <nowiki>https://apps.who.int/medicinedocs/en/m/abstract/Js22083en/</nowiki></ref> Figure 1 provides an overview of the link between disclosures of interests, and the identification and management of COI.
[[File:COI processes.jpg|center|frame|674x674px|<u>Figure 1.</u> An overview of processes involved in the disclosure and assessment of interests, and identification and management of COI]]
To facilitate such an assessment process for those involved in collecting and assessing disclosures of interests
•The WHO<sup>1</sup>, Haute Autorité de Santé (France)<sup>2</sup>, GIN<sup>3</sup>, NITAG<sup>4</sup>, and NICE<sup>5</sup> all outline factors to consider when assessing DOI for COI. These include:
* Relevancy/specificity to the topic<sup>1,2,3,5,</sup>
* Recency/currency <sup>1,2,4</sup>
* Frequency of the interest/relationship<sup>2,4</sup>
* Duration and depth of the relationship<sup>1,4</sup>
* Amount (for financial interests)<sup>1,4</sup>
* The role of the individual in the guideline process/decision-making<sup>1,2</sup>
Coming soon.
Coming soon.